Exocrine pancreatic insufficiency (EPI)

Exocrine pancreatic insufficiency, commonly known as EPI, is a serious digestive disorder in cats characterized by the pancreas failing to produce adequate amounts of digestive enzymes. These enzymes, including lipase, amylase, and proteases, are essential for breaking down fats, carbohydrates, and proteins in food. Without sufficient enzyme production, cats cannot properly digest and absorb nutrients from their diet, leading to malnutrition despite consuming adequate or even increased amounts of food. While EPI is less common in cats than in dogs, it represents a significant health concern that requires lifelong management once diagnosed.

The primary cause of EPI in cats differs from that seen in dogs. In felines, chronic pancreatitis is the most common underlying cause, leading to progressive destruction of the enzyme-producing acinar cells in the pancreas over time. This contrasts with dogs, where pancreatic acinar atrophy is the predominant cause. Other potential causes include pancreatic tumors that destroy functional tissue, severe acute pancreatitis that results in extensive tissue damage, and rarely, congenital abnormalities affecting pancreatic development. The condition typically develops gradually as pancreatic function progressively declines.

The impact of EPI on a cat's health can be profound and far-reaching. Affected cats experience significant weight loss, often appearing emaciated despite maintaining or even increasing their food intake. The malabsorption of nutrients leads to deficiencies in essential vitamins, particularly fat-soluble vitamins A, D, E, and K, as well as cobalamin (vitamin B12), which is crucial for neurological function and red blood cell production. Cats with untreated EPI may develop a dull, unkempt coat, experience chronic diarrhea with characteristically large, pale, greasy stools, and suffer from overall poor body condition. The constant nutrient deficiency can affect virtually every organ system over time.

The encouraging news for cat owners is that EPI is a manageable condition when properly diagnosed and treated. Treatment involves supplementing meals with pancreatic enzymes to replace what the cat's pancreas can no longer produce, along with dietary modifications and vitamin supplementation as needed. With appropriate management, most cats with EPI can achieve significant improvement in their symptoms, regain lost weight, and enjoy a good quality of life. Early detection is crucial, as prolonged malnutrition can lead to complications that are more difficult to reverse. Any cat showing unexplained weight loss, chronic digestive issues, or changes in stool character should be evaluated by a veterinarian promptly.

The primary cause of exocrine pancreatic insufficiency in cats is chronic pancreatitis, which accounts for the majority of feline EPI cases. Chronic pancreatitis involves ongoing inflammation of the pancreas that progressively destroys the acinar cells responsible for producing digestive enzymes. This inflammatory process can occur over months or years, gradually reducing the pancreas's ability to produce adequate enzymes until clinical signs of EPI become apparent. Research suggests that cats must lose approximately 90 percent of their pancreatic enzyme-producing capacity before obvious symptoms develop, which explains why the condition often goes undetected in its early stages.

Unlike in dogs, where genetic predisposition plays a significant role in EPI development, there is no strong evidence of hereditary factors contributing to feline EPI. However, certain conditions that predispose cats to chronic pancreatitis may indirectly increase the risk of developing EPI. Cats with inflammatory bowel disease (IBD) or cholangiohepatitis (inflammation of the bile ducts and liver) commonly develop concurrent pancreatitis as part of a condition known as triaditis, where all three organs are affected simultaneously. This interconnection between the gastrointestinal tract, liver, and pancreas means that diseases affecting one organ can precipitate problems in the others.

Environmental and lifestyle factors may contribute to the development of conditions that ultimately lead to EPI. Obesity has been associated with an increased risk of pancreatitis in cats, though the exact mechanism is not fully understood. Dietary factors, including high-fat diets or sudden dietary changes, may trigger pancreatic inflammation in susceptible individuals. Additionally, certain medications, toxins, and infectious agents have been implicated in causing acute pancreatitis, which if severe or recurrent, can progress to chronic pancreatitis and eventually EPI. Trauma to the abdomen, though less common, can also damage pancreatic tissue.

Several risk factors increase a cat's likelihood of developing EPI. Middle-aged to older cats are most commonly affected, likely due to the cumulative effects of chronic pancreatic inflammation over time. Cats with a history of recurrent acute pancreatitis episodes are at elevated risk, as each episode can cause additional damage to the enzyme-producing tissue. Cats with concurrent conditions such as diabetes mellitus, which also involves the pancreas, may have compromised pancreatic function. Additionally, cats that have undergone pancreatic surgery or experienced significant pancreatic trauma may develop EPI if sufficient tissue is lost or damaged.

The mechanism by which EPI develops involves the progressive loss of functional acinar cells in the exocrine portion of the pancreas. The pancreas has two main functional components: the endocrine portion, which produces hormones like insulin, and the exocrine portion, which produces digestive enzymes. In EPI, the exocrine function is specifically impaired while the endocrine function may remain intact, though both portions can be affected in some cases. As acinar cells are destroyed by inflammation, fibrosis, or other pathological processes, they are replaced by scar tissue that cannot produce enzymes. When the remaining functional tissue can no longer compensate for this loss, clinical EPI develops. The digestive enzymes normally released into the small intestine are no longer available in adequate quantities, resulting in maldigestion and malabsorption of nutrients from food.

The early warning signs of exocrine pancreatic insufficiency in cats can be subtle and easily overlooked, particularly because cats are masters at hiding illness. Initially, owners may notice their cat seems slightly thinner than usual or that the cat's appetite has increased without corresponding weight gain. The coat may begin to lose its normal luster and appear somewhat dull or dry. Some cats may have occasional episodes of soft stool that owners attribute to dietary indiscretion or hairballs. Because these early signs develop gradually and cats typically maintain their normal behavior patterns, EPI often progresses significantly before a diagnosis is sought. The insidious onset means that by the time obvious symptoms appear, substantial pancreatic function has already been lost.

The most common and characteristic symptoms of EPI include dramatic weight loss despite a normal or increased appetite, a phenomenon sometimes described as the cat "eating everything in sight" while continuing to waste away. Affected cats often produce large volumes of stool that may be pale, greasy, or have an unusually foul odor due to the high fat content from malabsorption. The stool consistency is typically soft to liquid, and cats may have increased frequency of defecation. Some cats develop flatulence and borborygmi (stomach rumbling sounds) due to bacterial fermentation of undigested nutrients in the intestines. Coprophagia, or eating feces, may occur as the cat attempts to recover lost nutrients, though this behavior is more common in dogs with EPI.

Behavioral changes associated with EPI can be significant and distressing for both the cat and owner. Despite the increased appetite, cats may become irritable or anxious around feeding times, possibly due to persistent hunger from inadequate nutrient absorption. Lethargy and decreased activity levels often develop as the cat's body lacks the energy normally derived from proper digestion. Some cats become less social and may hide more frequently, which is a common feline response to feeling unwell. Changes in grooming behavior may be noted, with affected cats grooming less frequently or less thoroughly, contributing to the poor coat condition.

Physical signs observable by owners and veterinarians include obvious muscle wasting and loss of body condition, often most noticeable over the spine, hips, and shoulders where bones may become prominently visible. The coat typically appears dull, dry, and may have excessive dandruff or a greasy texture in some cases. Cats may develop vitamin deficiencies that manifest in various ways: vitamin A deficiency can cause skin and eye problems, vitamin K deficiency may lead to bleeding tendencies, and vitamin E deficiency can cause muscle weakness. The abdomen may appear tucked up due to loss of abdominal fat. Some cats develop secondary skin conditions due to nutritional deficiencies, including dry, flaky skin or poor wound healing.

Symptom progression in EPI typically follows a pattern of gradual worsening without treatment. Initially, cats may maintain relatively stable weight with only mild digestive disturbances, but as pancreatic function continues to decline, weight loss accelerates and stool abnormalities become more pronounced. Cobalamin (vitamin B12) deficiency frequently develops and can cause additional symptoms including neurological signs such as weakness or unsteady gait in severe cases. Some cats develop small intestinal bacterial overgrowth (SIBO) as a secondary complication, which can worsen diarrhea and contribute to further malabsorption. Without intervention, affected cats become progressively cachectic and may develop complications from severe malnutrition.

Emergency symptoms requiring immediate veterinary care include severe dehydration from persistent diarrhea, complete loss of appetite or inability to keep any food down, extreme weakness or collapse, pale gums suggesting anemia, and any neurological symptoms such as seizures or severe incoordination. While EPI itself is rarely acutely life-threatening, the complications from severe malnutrition and dehydration can become critical. Additionally, because EPI in cats is often associated with concurrent conditions like pancreatitis, IBD, or liver disease, symptoms of these conditions may overlap and require urgent attention. Any cat with known EPI that suddenly worsens or develops new symptoms should be evaluated promptly to rule out complications or concurrent disease flares.

The diagnostic process for exocrine pancreatic insufficiency begins with a thorough veterinary examination and detailed history. During the initial visit, the veterinarian will perform a complete physical examination, noting the cat's body condition score, coat quality, and any signs of muscle wasting. Palpation of the abdomen may reveal changes consistent with gastrointestinal disease, though the pancreas itself is rarely palpable even when diseased. The veterinarian will ask detailed questions about the cat's appetite, weight changes, stool characteristics, eating behaviors, and any previous health issues. A complete history helps differentiate EPI from other conditions causing similar symptoms and may reveal clues pointing toward underlying causes such as previous pancreatitis episodes.

The definitive diagnostic test for EPI in cats is measurement of feline trypsin-like immunoreactivity (fTLI) in the blood. This test measures the concentration of trypsinogen, a digestive enzyme precursor produced exclusively by the pancreas, in the bloodstream. In cats with EPI, fTLI levels are significantly decreased, typically below 8 micrograms per liter, while the normal reference range is 12-82 micrograms per liter. The test requires a 12-hour fast before blood collection to ensure accurate results. Additional blood tests typically performed include a complete blood count (CBC) to check for anemia and signs of inflammation, a comprehensive metabolic panel to assess organ function and electrolyte balance, and serum cobalamin (vitamin B12) and folate levels to evaluate for deficiencies commonly associated with EPI and small intestinal disease.

Differential diagnosis is crucial because several conditions can mimic the symptoms of EPI. Inflammatory bowel disease can cause similar weight loss and diarrhea, and frequently occurs concurrently with EPI in cats. Intestinal lymphoma, a relatively common cancer in older cats, presents with comparable clinical signs. Hyperthyroidism causes weight loss with increased appetite and is common in older cats. Diabetes mellitus also causes weight loss despite increased food intake. Intestinal parasites, chronic kidney disease, and other malabsorptive conditions must also be ruled out. The veterinarian may recommend additional testing including fecal examination for parasites, thyroid hormone levels, abdominal ultrasound to evaluate the pancreas and other abdominal organs, and in some cases, intestinal biopsies to rule out IBD or lymphoma.

Once EPI is confirmed through low fTLI levels, additional testing helps characterize the extent of disease and guide treatment. Cobalamin levels are particularly important, as the majority of cats with EPI have concurrent cobalamin deficiency that must be addressed for successful management. Folate levels may be elevated in cats with small intestinal bacterial overgrowth, a common secondary complication. Abdominal ultrasound can reveal changes in the pancreas consistent with chronic pancreatitis, such as decreased size, irregular margins, or altered echogenicity, though the pancreas can appear normal in some cases. If concurrent conditions are suspected, additional diagnostics such as liver enzyme evaluation, bile acids testing, or intestinal biopsies may be recommended. The diagnostic workup helps the veterinarian develop a comprehensive treatment plan addressing not only the EPI but also any underlying or concurrent conditions contributing to the cat's clinical signs.

Treatment for exocrine pancreatic insufficiency in cats requires immediate initiation of enzyme replacement therapy to restore digestive function. The cornerstone of EPI management is supplementing each meal with pancreatic enzymes, typically derived from porcine (pig) pancreas sources. These enzyme supplements are available in powder form, which is generally most effective, or as capsules and tablets. The enzymes must be mixed thoroughly with the food immediately before feeding to ensure adequate distribution. Initial dosing typically starts at one teaspoon of powdered enzyme per cup of food, though the exact amount is adjusted based on individual response. Some veterinarians recommend pre-incubating the enzyme-food mixture for 20-30 minutes before feeding to enhance enzyme activation, though this practice is debated and may not be necessary for all cats.

Medical management extends beyond enzyme supplementation to address the nutritional deficiencies that accompany EPI. Cobalamin (vitamin B12) supplementation is essential for most cats with EPI, as malabsorption prevents adequate uptake of this crucial vitamin from food. Cobalamin can be administered via injection, typically weekly initially then tapering to monthly maintenance doses, or through daily oral supplementation using high-dose formulations designed for adequate absorption despite intestinal dysfunction. Folate supplementation may be needed if levels are low. Some cats benefit from vitamin E supplementation, and in rare cases where bleeding tendencies develop, vitamin K supplementation may be necessary. Regular monitoring of vitamin levels helps guide ongoing supplementation needs.

While EPI itself rarely requires surgical intervention, surgery may be indicated for underlying conditions or complications. If a pancreatic tumor is identified as the cause of EPI, surgical removal may be considered depending on the tumor type and extent. Cats with concurrent conditions such as biliary obstruction or intestinal masses may require surgical intervention for those specific problems. In general, however, EPI management is medical rather than surgical. The focus is on replacing lost enzyme function and supporting nutritional status rather than attempting to restore pancreatic function, which is not currently possible with available treatments.

Supportive care plays a vital role in helping cats with EPI regain health and maintain quality of life. Dietary management is important, though recommendations have evolved over time. Previously, highly digestible, low-fat diets were universally recommended, but current evidence suggests that many cats with EPI do well on moderate-fat diets as long as adequate enzyme supplementation is provided. Some cats benefit from increased feeding frequency with smaller meals throughout the day rather than one or two large meals. Ensuring adequate hydration is important, particularly in cats with ongoing diarrhea. Appetite stimulants may be needed initially if the cat has developed food aversion or reduced appetite.

Complementary and alternative approaches may provide additional benefit for some cats with EPI, though evidence supporting specific therapies is limited. Probiotics may help establish healthy intestinal bacterial populations and reduce symptoms of bacterial overgrowth. Prebiotics, which promote growth of beneficial bacteria, are sometimes recommended. Medium-chain triglycerides (MCTs), which can be absorbed without requiring pancreatic enzymes, may provide an additional calorie source for severely underweight cats. Some owners report improvement with raw pancreas supplementation as an alternative to commercial enzyme products, though this approach carries potential food safety risks and is not universally recommended. Herbal supplements claiming to support pancreatic function lack scientific evidence in cats and should be approached with caution.

Treatment decisions are influenced by multiple factors including the severity of clinical signs, presence of concurrent conditions, response to initial therapy, and practical considerations such as cost and ease of administration. Pancreatic enzyme supplements represent an ongoing expense that owners must be prepared to manage long-term. Some enzyme products are more palatable than others, and finding a formulation the cat accepts may require trial and error. Cats with concurrent IBD or pancreatitis may require additional medications such as immunosuppressive drugs or anti-nausea medications. The treatment plan should be individualized based on the specific cat's needs and regularly reassessed as the condition is managed over time. With appropriate treatment, most cats show significant improvement within the first few weeks, though achieving optimal management may take several months of adjustment.

Recovery from the initial presentation of exocrine pancreatic insufficiency varies depending on the severity of malnutrition and presence of concurrent conditions, but most cats begin showing improvement within one to two weeks of starting appropriate treatment. The first signs of response typically include improved stool consistency, with feces becoming more formed and less voluminous. Weight stabilization usually occurs within the first few weeks, followed by gradual weight gain over the subsequent months. Coat quality improvement takes longer, often several months, as the body redirects nutrients toward more critical functions before addressing coat condition. Full recovery to optimal body weight and condition may take three to six months or longer, particularly in severely affected cats. Owners should understand that while significant improvement is expected, the goal is management rather than cure.

Post-treatment care requires consistent attention to enzyme supplementation, dietary management, and monitoring. Enzyme supplements must be given with every meal without exception for the remainder of the cat's life. Missing doses will result in return of symptoms, as the underlying pancreatic dysfunction is permanent. Cobalamin supplementation frequency may decrease over time once levels normalize, but many cats require ongoing supplementation at reduced intervals. Regular weighing at home helps track progress and detect any regression early. Follow-up veterinary visits are typically scheduled at two to four weeks after starting treatment to assess initial response, then every three to six months for ongoing monitoring once the cat is stable.

The prognosis for cats with EPI depends on several factors including the underlying cause, presence of concurrent diseases, and response to treatment. Cats with EPI secondary to chronic pancreatitis may experience ongoing pancreatic inflammation that requires additional management. Those with concurrent IBD or liver disease often have a more complicated course and may require multiple medications. The presence of severe cobalamin deficiency at diagnosis, particularly if neurological signs have developed, may indicate a more guarded prognosis for complete recovery. However, cats that respond well to enzyme supplementation and have their nutritional deficiencies corrected generally have a good long-term prognosis. EPI itself, when properly managed, does not typically shorten life expectancy significantly.

Long-term outlook for cats with well-managed EPI is generally positive, with many cats living normal lifespans and enjoying good quality of life. The condition requires lifelong commitment to daily enzyme supplementation, which becomes routine for most owners over time. Some cats may experience occasional flares of digestive symptoms, particularly if enzyme dosing is inadequate or if concurrent conditions worsen. Regular veterinary monitoring helps detect and address any changes before they become serious. Owners should be prepared for the ongoing costs of enzyme supplements and periodic veterinary care but can take comfort in knowing that EPI, despite being incurable, is highly manageable. With consistent care, cats with EPI can thrive and maintain excellent quality of life for years following diagnosis.

Primary prevention of exocrine pancreatic insufficiency centers on reducing the risk of chronic pancreatitis, the most common underlying cause in cats. Maintaining a healthy body weight is one of the most important preventive measures, as obesity has been associated with increased pancreatitis risk. Feeding a consistent, high-quality diet appropriate for the cat's life stage and avoiding sudden dietary changes can help protect pancreatic health. While no specific diet has been proven to prevent EPI, avoiding excessive dietary fat and ensuring balanced nutrition supports overall digestive system health. Regular veterinary checkups allow early detection of conditions that may predispose to pancreatitis, enabling intervention before significant pancreatic damage occurs.

Environmental factors play a role in preventing conditions that lead to EPI. Keeping cats indoors reduces exposure to toxins, infectious agents, and trauma that could damage the pancreas. Ensuring cats cannot access human medications, household chemicals, or toxic plants is essential, as certain substances can trigger acute pancreatitis. Minimizing stress through environmental enrichment, consistent routines, and appropriate multi-cat household management may help reduce inflammation throughout the body, including the pancreas. While these measures cannot guarantee prevention of EPI, they contribute to overall health and may reduce risk factors.

Dietary considerations for prevention include feeding appropriate portions to maintain healthy weight, providing fresh water to ensure adequate hydration, and choosing foods with high-quality, digestible ingredients. Some veterinarians recommend avoiding extremely high-fat treats or table scraps, particularly in cats with any history of digestive sensitivity. For cats that have experienced acute pancreatitis, strict dietary management to prevent recurrence is crucial, as repeated episodes increase the risk of chronic pancreatitis and subsequent EPI. Prescription digestive diets may be recommended for cats with known pancreatic sensitivity to reduce workload on the pancreas.

Routine health maintenance supports pancreatic health as part of overall wellness. Annual or semi-annual veterinary examinations allow detection of early warning signs before conditions progress. Blood work screening, particularly in middle-aged and senior cats, can identify early changes suggesting pancreatic inflammation or other diseases that might predispose to EPI. Prompt treatment of acute pancreatitis episodes with appropriate supportive care, anti-nausea medications, and pain management may help limit pancreatic damage. Managing concurrent conditions such as inflammatory bowel disease or liver disease that are associated with pancreatitis can reduce overall inflammatory burden.

Early intervention is key when any signs of pancreatic disease develop. Owners should seek veterinary attention promptly if their cat shows decreased appetite, vomiting, lethargy, or abdominal discomfort, which may indicate pancreatitis. Early, aggressive treatment of pancreatitis may preserve pancreatic function and prevent progression to EPI. For cats with known chronic pancreatitis, working closely with the veterinarian to optimize management can slow progression and potentially delay or prevent development of clinical EPI. While not all cases of EPI can be prevented, particularly when underlying causes are unclear, proactive health management and prompt attention to early warning signs give cats the best chance of maintaining normal pancreatic function throughout their lives.

Daily management of a cat with exocrine pancreatic insufficiency requires establishing consistent routines around feeding and enzyme supplementation. Every meal must include the prescribed amount of pancreatic enzyme supplement, mixed thoroughly with the food before offering it to the cat. Many owners find it helpful to prepare enzyme-food mixtures in advance for the day's meals, though the mixture should not sit for extended periods. Feeding multiple smaller meals throughout the day, typically three to four meals, may improve digestion and nutrient absorption compared to one or two large meals. The daily routine should include monitoring food intake, observing stool quality, and noting any changes in appetite or behavior that might indicate a problem.

Home environment modifications can help cats with EPI maintain comfort and manage their condition. Multiple litter boxes kept scrupulously clean encourage regular elimination and allow owners to monitor stool quality easily. Comfortable, easily accessible resting spots help cats conserve energy, particularly during the initial recovery phase when strength is rebuilding. If the cat has difficulty maintaining body temperature due to loss of body fat and muscle, providing warm bedding and ensuring the home is kept at a comfortable temperature becomes important. Food and water stations should be easily accessible, especially for cats that may be weakened from malnutrition.

Maintaining quality of life for cats with EPI involves more than managing the medical condition. Once nutritional status improves, cats should be encouraged to engage in normal activities including play, exploration, and social interaction. Mental stimulation through interactive toys, puzzle feeders (adapted for enzyme-supplemented food), and environmental enrichment supports overall well-being. Most cats with well-managed EPI can participate in all normal feline activities without restriction. Owners should celebrate improvements and milestones, such as weight gain and coat improvement, while remaining vigilant for any regression that might indicate a need for treatment adjustment.

Ongoing monitoring and veterinary care are essential components of living with a cat with EPI. Owners should maintain a log of daily observations including food intake, enzyme dosing, stool quality, and body weight. Weekly weigh-ins at home help track trends and detect changes early. Any sudden worsening of symptoms, particularly return of diarrhea, weight loss, or decreased appetite, warrants veterinary consultation. Regular check-ups, typically every three to six months for stable cats, include physical examination, body weight assessment, and periodic blood work to monitor cobalamin levels and overall health. Communication with the veterinary team about any concerns ensures optimal ongoing management.

Caregiver support is an important but often overlooked aspect of managing a cat with EPI. The ongoing demands of daily enzyme supplementation, monitoring, and veterinary care can be stressful, particularly in the early stages of diagnosis and treatment. Connecting with online communities of other EPI cat owners can provide valuable emotional support and practical tips. Financial planning for ongoing enzyme supplement costs, which can be substantial, helps reduce stress about long-term management. Owners should also establish backup plans for enzyme supplementation during travel or emergencies, ensuring the cat's care continues uninterrupted. Many owners find that once routines are established, managing EPI becomes second nature, and the reward of seeing their cat healthy and thriving makes the effort worthwhile.

Unlike in dogs, where certain breeds such as German Shepherds have a well-documented genetic predisposition to exocrine pancreatic insufficiency, no specific cat breeds have been definitively identified as having increased risk for EPI. The condition appears to occur with similar frequency across all breeds and mixed-breed cats. However, because chronic pancreatitis is the primary cause of feline EPI, breeds with higher rates of pancreatitis may be indirectly at increased risk. Some studies have suggested that Siamese cats may have higher rates of pancreatic disease, though this association is not conclusively established. Domestic shorthair and domestic longhair cats, simply by virtue of their prevalence in the pet population, represent the majority of diagnosed EPI cases.

While specific breed predisposition is not recognized, certain cat populations may have elevated risk factors worth monitoring. Middle-aged to older cats of any breed are most commonly diagnosed with EPI, reflecting the time required for chronic pancreatitis to cause sufficient pancreatic damage. Cats with histories of recurrent gastrointestinal issues, regardless of breed, should be monitored for signs of developing EPI. Cats diagnosed with inflammatory bowel disease, cholangiohepatitis, or triaditis (concurrent disease of the intestines, liver, and pancreas) are at increased risk due to the inflammatory interconnection between these organs. Obese cats of any breed face elevated pancreatitis risk and therefore potential EPI development.

Given the lack of clear breed predisposition, screening recommendations for EPI focus on clinical signs rather than breed-based testing. Routine screening of healthy cats for EPI is not currently recommended, as the condition is relatively uncommon and the fTLI test is not typically included in standard wellness panels. However, veterinarians should maintain a high index of suspicion for EPI in any cat presenting with unexplained weight loss, chronic diarrhea, or poor body condition. Cats with known chronic pancreatitis may benefit from periodic monitoring of pancreatic function. Owners acquiring cats from breeders should inquire about any family history of pancreatic disease, though comprehensive genetic testing for EPI risk is not currently available for cats. Future research may identify genetic markers that could enable more targeted screening and prevention strategies.

Exocrine pancreatic insufficiency in cats frequently occurs alongside several related conditions, most notably as part of a syndrome known as triaditis. Triaditis involves concurrent inflammation of the pancreas (pancreatitis), liver and bile ducts (cholangiohepatitis), and small intestine (inflammatory bowel disease). These three organs share anatomical connections through the bile duct system, allowing inflammation to spread between them. Cats with EPI secondary to chronic pancreatitis often have some degree of IBD or liver involvement, complicating both diagnosis and management. Treatment of these concurrent conditions may require additional medications such as immunosuppressive drugs, antibiotics, or hepatoprotectants, and outcomes depend on successful management of all affected organs.

Several conditions present with symptoms similar to EPI and must be distinguished through appropriate diagnostic testing. Inflammatory bowel disease causes chronic diarrhea and weight loss but typically responds to immunosuppressive therapy rather than enzyme supplementation. Intestinal lymphoma, particularly the small cell variant common in older cats, can be challenging to differentiate from IBD and may occur concurrently with EPI. Hyperthyroidism causes weight loss with increased appetite and activity, typically affecting cats over eight years of age. Diabetes mellitus causes weight loss, increased appetite, and increased thirst and urination. Food allergies or intolerances may cause chronic gastrointestinal signs. Accurate differentiation requires specific testing including fTLI for EPI, intestinal biopsies for IBD and lymphoma, and hormone testing for hyperthyroidism.

Complications and secondary conditions that may develop in cats with EPI include cobalamin deficiency, which occurs in the majority of affected cats and can cause anemia and neurological dysfunction if untreated. Small intestinal bacterial overgrowth (SIBO) develops when undigested nutrients provide substrate for bacterial proliferation, worsening diarrhea and malabsorption. Cats with EPI may develop deficiencies of fat-soluble vitamins (A, D, E, K) leading to various clinical manifestations. Severe, prolonged malnutrition can affect immune function, wound healing, and organ function throughout the body. Monitoring for these complications and addressing them promptly is essential for optimal outcomes. Additionally, cats with EPI remain at risk for acute pancreatitis flares, which may cause temporary worsening of symptoms and require additional supportive care during episodes.